根据最新提交给美国证券交易委员会（SEC）的文件披露，医疗设备制造商麦斯莫医疗（Masimo Corporation）与丹纳赫集团（Danaher Corporation）的潜在交易中设置了一项关键条款。文件明确规定，若此项交易在特定预设情形下被终止，麦斯莫医疗需向丹纳赫支付高达3.05亿美元的解约费用。
该条款为交易增添了重要的财务保障机制，凸显了双方在谈判中对交易执行风险的考量。巨额终止费的存在，通常旨在确保交易各方严肃对待协议承诺，并补偿一方在交易未能完成时可能遭受的损失。
根据最新提交给美国证券交易委员会（SEC）的文件披露，医疗设备制造商麦斯莫医疗（Masimo Corporation）与丹纳赫集团（Danaher Corporation）的潜在交易中设置了一项关键条款。文件明确规定，若此项交易在特定预设情形下被终止，麦斯莫医疗需向丹纳赫支付高达3.05亿美元的解约费用。
该条款为交易增添了重要的财务保障机制，凸显了双方在谈判中对交易执行风险的考量。巨额终止费的存在，通常旨在确保交易各方严肃对待协议承诺，并补偿一方在交易未能完成时可能遭受的损失。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.